<DOC>
	<DOC>NCT02355249</DOC>
	<brief_summary>This study is a multi-center, randomized, and open-label trial to compare the safety and feasibility of traditional three incisions and minimally invasive thoracol-laparoscopic esophagectomy for esophageal cancer.</brief_summary>
	<brief_title>Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<criteria>1. Histologic diagnosis of intrathoracic esophageal carcinoma of Stage I to III, which is potentially resectable judged by MDT 2. 18≤age≤75 3. cT1b4a，N02，M0 confirmed by chest CT, EUS, or EUSFNA in four weeks; 4. ECOG PS scores≤2 5. Laboratory findings in 14 days before operation：normal blood test of basic metabolism panel 6. European Clinical Oncology Group (ECOG) performance status 0,1 or 2 7. More than 12 months of expected survival 8. Tolerance of tracheal intubation and general anesthesia 9. Written informed consent 1. Carcinoma of the cervical esophagus or gastroesophageal junction (GEJ) 2. Prior thoracic surgery which may effect this study 3. Pregnant or breast feeding 4. Inability to tolerance of tracheal intubation and general anesthesia 5. PS &gt;2 6. unstable disease 7. Poor compliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>traditional three incisions</keyword>
	<keyword>minimally invasive thoracol-laparoscopic esophagectomy</keyword>
	<keyword>MIE</keyword>
	<keyword>esophageal cancer</keyword>
</DOC>